New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: Mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors

详细信息    查看全文

• 作者：Alex ; ra Szlachcic ; Zbigniew Sliwowski ; Gracjana Krzysiek-Maczka ; Jolanta Majka ; Marcin Surmiak ; Robert Pajdo ; Danuta Drozdowicz ; Stanislaw J. Konturek ; Tomasz Brzozowski
• 关键词：Nesfatin-1 ; Gastroprotection ; Stress ; Gastric blood flow ; Prostaglandins ; Nitric oxide ; Sensory nerves ; Calcitonin gene-related peptide ; Vagal nerves
• 刊名：Peptides
• 出版年：November, 2013
• 年：2013
• 卷：49
• 期：Complete
• 页码：9-20
• 全文大小：3247 K

文摘

Nesfatin-1 belongs to a family of anorexigenic peptides, which are responsible for satiety and are identified in the neurons and endocrine cells within the gut. These peptides have been implicated in the control of food intake; however, very little is known concerning its contribution to gastric secretion and gastric mucosal integrity. In this study the effects of nesfatin-1 on gastric secretion and gastric lesions induced in rats by 3.5 h of water immersion and restraint stress (WRS) were determined. Exogenous nesfatin-1 (5-40 渭g/kg i.p.) significantly decreased gastric acid secretion and attenuated gastric lesions induced by WRS, and this was accompanied by a significant rise in plasma NUCB2/nefatin-1 levels, the gastric mucosal blood flow (GBF), luminal NO concentration, generation of PGE₂ in the gastric mucosa, an overexpression of mRNA for NUBC2 and cNOS, as well as a suppression of iNOS and proinflammatory cytokine IL-1尾 and TNF-伪 mRNAs. Nesfatin-1-induced protection was attenuated by suppression of COX-1 and COX-2 activity, the inhibition of NOS with L-NNA, the deactivation of afferent nerves with neurotoxic doses of capsaicin, and the pretreatment with capsazepine to inhibit vanilloid VR1 receptors. This study shows for the first time that nesfatin-1 exerts a potent protective action in the stomach of rats exposed to WRS and these effects depend upon decrease in gastric secretion, hyperemia mediated by COX-PG and NOS-NO systems, the activation of vagal and sensory nerves and vanilloid receptors.